tiprankstipranks
Paradigm Biopharmaceuticals Ltd. (AU:PAR)
ASX:PAR

Paradigm Biopharmaceuticals Ltd. (PAR) Stock News & Sentiment

1 Followers
Paradigm Submits Phase 3 OA Program to FDA
PremiumCompany Announcements
Paradigm Submits Phase 3 OA Program to FDA
15d ago
Paradigm Biopharmaceuticals Ltd. (AU:PAR) has released an update. Paradigm Biopharmaceuticals Ltd. has made significant strides by submitting a comprehensive package, including new nonclinical study results and phase 2 clinical trial ...Read more
Paradigm Bio Cancels Shares in Buy-Back Scheme
PremiumCompany Announcements
Paradigm Bio Cancels Shares in Buy-Back Scheme
29d ago
Megaport (ASX:MP1) makes the “Perfect 10” Smart Score list
PremiumStock Analysis & Ideas
Megaport (ASX:MP1) makes the “Perfect 10” Smart Score list
2y ago

News Score - Last 7 Days

Neutral
AU:PAR
Sector Average
Media Buzz
This Week5 articles
Weekly Average1.25 articles
News Sentiment
This Week50%
Sector Average62%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AU:PAR’s Media Buzz Sentiment?
5 articles about AU:PAR were published this week. In an average week, 1.25 articles are published.
    What is AU:PAR’s weekly average amount of articles?
    In an average week, 1.25 articles about AU:PAR are published.
      What is AU:PAR’s News Sentiment?
      50% of articles about AU:PAR were positive this week, compared to its sector average of 62%.
        Healthcare Stocks that are Trending in the News
        ELVElevance Health
        CGEMCullinan Management
        MRNSMarinus
        EWEdwards Lifesciences
        INSPInspire Medical Systems
        Showing the stocks with the most bullish news sentiment over the past week
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis